Research | Page 118 of 638 | SpiritIndia.com

Influenza :: Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks

An analysis of non-pharmaceutical interventions used in the U.S. during the 1918-1919 influenza pandemic, such as closing schools and banning public gatherings, found an association between these interventions and reduced death rates, suggesting that non-pharmaceutical interventions may play a role in planning for future influenza pandemics, according to a study in the August 8 issue of JAMA.

ADHD :: ADHD appears to be associated with depressed dopamine activity in brain

Adults with attention-deficit/hyperactivity disorder (ADHD) show a blunted response to the drug methylphenidate (Ritalin), which increases brain dopamine levels, according to a report in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals. This suggests that dopamine dysfunction may be involved with ADHD symptoms and may contribute to substance abuse that often occurs simultaneously.

HIV :: FDA approves antiretroviral drug Maraviroc for HIV patients

The U.S. Food and Drug Administration (FDA) approved maraviroc, an antiretroviral drug for use in adult HIV patients. Maraviroc, sold under the trade name Selzentry, is the first in a new class of drugs designed to slow the advancement of HIV and received priority review by the FDA.

Coffee & caffeine may protect memory in older women

Drinking more than three cups of coffee (or the equivalent in tea) per day or caffeine may help older women protect their thinking skills, according to a study published in the August 7, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.

Melanoma :: Research shows incidence of melanoma on the rise

Over the past several decades, the incidence of melanoma ? the most serious form of skin cancer ? has steadily increased in the United States. From 1995 to 2004, melanoma has increased by more than 1 percent per year in this country ? in sharp contrast to overall cancer rates that have steadily decreased by 0.6 percent per year during this time.

Skin :: New study finds common skin conditions misconstrued as contagious could affect social lives of young adults

When it comes to being lucky in love, new research examining knowledge and attitudes about contagious diseases in Americans 18 to 25 years of age suggests that people with psoriasis and eczema may be at a distinct disadvantage.

Skin :: New technologies tighten skin from head to toe without surgery

If sagging skin is getting you down, recent advances in skin-tightening technologies can lift your spirits ? and your skin ? in a matter of a few office visits to your dermatologist. The beauty of these non-invasive procedures is their ability to treat loose skin virtually anywhere on the body without the risks and downtime associated with surgery.

Healthcare :: RAND, Health Dialog form alliance to create tools to evaluate health care quality and efficiency

The RAND Corporation and Health Dialog Services Corporation today announced an alliance that will entitle Health Dialog to exclusive, worldwide rights to integrate select RAND quality measures into its existing provider performance measurement tools and care management services.

Heart Failure :: Novel candidate biomarker for heart failure also strongly predicts risk of death

A potential new biomarker for heart failure may be more powerful than established measures in identifying patients at increased risk for death from several causes. In a report to appear in the Journal of the American College of Cardiology that has received early online release, an international research team describes finding that blood levels of a protein called ST2 both indicate the presence of heart failure among patient with shortness of breath and powerfully predict the risk that a patient will die during the following year.

Acne :: New oral acne medications poised to benefit patients

While laser and light-based therapies continue to make their mark on many dermatologic procedures, some dermatologists believe the tried-and-true oral medications for treating moderate to severe acne offer patients the best long-term treatment outcomes. In fact, the introduction of new oral acne medications demonstrates that the demand for systemic acne therapies is still strong.